626P Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice: Interim analysis of the non-interventional SCOPE study

Autor: Bokemeyer, C., Amram, M-L., Stoiber, F., Gschwend, J.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S517-S517
Databáze: ScienceDirect